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Intrinsic radiosensitivity of human pancreatic tumour cells and the
radiosensitising potency of the nitric oxide donor sodium nitroprusside
VN Verovski, DL Van den Berge, GA Soete, BL Bols and GA Storme
Cancer Research Unit, Department ofRadiotherapy, Oncology Center, Academic Hospital, Free University Brussels, 1090 Brussels,
Belgium.
Summary A panel of eight human pancreatic tumour cell lines displayed high intrinsic radioresistance, with
mean inactivation doses between 2.4 and 6.5 Gy, similar to those reported for melanoma and glioblastoma.
The radiosensitising potency of sodium nitroprusside, a bioreductive nitric oxide donor, was assessed in a
model of metabolism-induced hypoxia in a cell micropellet. Sodium nitroprusside at 0.1 mm revealed a
radiosensitising effect with an overall enhancement ratio of 1.9 compared with 2.5 for oxygen. Radiosensitising
activity correlated with the enhancement of single-strand DNA breakage caused by radiation. In suspensions
with cell densities of between 3% and 30% (v/v), the half-life of sodium nitroprusside decreased from 31 to
3.2 min, suggesting a value ofaround min for micropellets. Despite this variation, the radiosensitising activity
was similar in micropellets and in diluted cell suspensions. S-nitroso-L-glutathione was found to possess
radiosensitising activity, consistent with a possible role of natural thiols in the storing of radiobiologically
active nitric oxide adducts derived from sodium nitroprusside. As measured by a nitric oxide-specific
microsensor, activation of sodium nitroprusside occurred by bioreduction, whereas S-nitroso-L-glutathione
showed substantial spontaneous decomposition. Both agents appear to exert radiosensitising action through
nitric oxide as its scavenging by carboxy phenyltetramethylimidazolineoxyl N-oxide (carboxy-PTIO) and
oxyhaemoglobin resulted in attenuated radiosensitisation. Sodium nitroprusside was at least 10-fold more
potent than etanidazole, a 2-nitroimidazole used as a reference. Our data suggest that sodium nitroprusside, a
drug currently used for the treatment of hypertension, is a potential tumour radioresponse modifier.
Keywords: human pancreatic tumour; hypoxic cell radiosensitisation; sodium nitroprusside; S-nitroso-L-
glutathione; nitric oxide
Adenocarcinoma of the pancreas is the fourth leading cause
of cancer-related deaths and represents a type of tumour
refractory to radiotherapy (Brennan et al., 1993). The poor
response rates to external beam radiotherapy may be
explained by the proximity of many dose-limiting organs
and possibly by intrinsic and hypoxia-induced radioresistance
as well. The latter factor is of considerable interest, because
hypoxic cells can be specifically targeted by electron-affinic
compounds such as nitroimidazoles and bioreductive
cytotoxins (Adams, 1992).
Nitric oxide (NO) is a relatively long-life radical generated
endogenously by nitric oxide synthases, and has been
implicated in signal transduction in the nervous and vascular
system and as a cytotoxin in pathophysiological processes
related to cellular immunity and hypoxia -reoxygenation
injury (Knowles and Moncada, 1994). NO, in gaseous form
or released chemically from the NONOate complex DEA/
NO, has also been shown to radiosensitise hypoxic cells. The
mechanism of NO-mediated radiosensitisation has been
postulated to be the fixation of radiation-induced DNA
damage, thus mimicking the effects of oxygen on DNA
lesions (Howard-Flanders, 1957; Mitchell et al., 1993).
In the present study we investigated the radiosensitivity of
established human pancreatic tumour cell lines with a range
of growth rates and differentiation grades. The radio-
biological parameters of pancreatic tumour cells have not
yet been extensively analysed. Another objective was to
explore the radiosensitising potency and DNA-targeting
properties of sodium nitroprusside (SNP), containing NO in
the form of nitrosonium cation coordinated to the iron-
cyanide complex. SNP is a clinically used vasodilator with a
well-known pharmacology and toxicity. Whereas NONOates
release NO spontaneously in aqueous media (Maragos et al.,
1991, 1993), SNP is activated by a one-electron transfer
reduction (Bates et al., 1991). This reaction may be catalysed
by thiols with an optimum pH of 6 -7, common for
metabolism-induced hypoxia in solid tumours. Therefore,
we examined the radiosensitising activity of SNP using a
metabolism-mediated hypoxia model. We also analysed the
rate of SNP bioactivation at different cell densities and
explored the role of NO using a specific microsensor and the
scavengers 2-(4-carboxyphenyl)-4,4,5,5-tetramethyllimidazo-
lene-l-oxyl-3-oxide (carboxy-PTIO) and oxyhaemoglobin.
Another NO donor investigated here was S-nitroso-L-
glutathione (GSNO). This agent represents the major
product of NO interaction with intracellular thiols (Clancy
et al., 1994) and thus may be involved in metabolic pathways
of the nitrosonium cation derived from SNP. The chemical
agents generating NO after reductive bioactivation can be
regarded as a novel class of hypoxic tumour cell radio-
sensitisers.
Materials and methods
Chemicals
Carboxy-PTIO and GSNO were purchased from Alexis
(Laufelfingen, Switzerland). Other chemicals were obtained
from Sigma (St Louis, MO, USA). The stocks of SNP,
GSNO and carboxy-PTIO were prepared in medium before
use.
Cell culture
All human pancreatic tumour cell lines were of ductal origin
and were kindly provided by Dr G Kl6ppel (Department of
Pathology, Academic Hospital, Free University of Brussels,
Belgium). The doubling times for the cell lines PSN1,
Mia Paca 2, PT45, PaTu 2, Panc-l, HPAF, Colo 357 and
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1996A818-7 were 21, 23, 23, 25, 32, 29, 32 and 45 h respectively.
The last four cell lines display the highest degree of
morphological and immunocytochemical differentiation
(Maillet et al., 1993). PSN1/ADR is a multidrug-resistant
subline established in our laboratory from PSN1 by selection
in 170 nM doxorubicin (Verovski et al., 1996). The adherent
cultures were maintained in RPMI 1640 medium (Gibco,
Paisley, UK) supplemented with 10% bovine calf serum
(HyClone Laboratories, Logan, UT, USA) at 37°C in 5%
carbon dioxide/95% air. All in vitro experiments were carried
out on plastic tissue culture plates (Greiner, Frickenhausen,
Germany).
Radiation
Cultures grown to early confluence were trypsinised, and the
cells were washed by centrifugation in medium and counted.
All steps in sample preparation and processing were
performed at 0°C, unless otherwise stated. Cells were
irradiated at 37°C at a dose rate of 2 Gy min-' using an
8 MV photon beam from a linear accelerator and
immediately cooled.
Intrinsic radiosensitivity was assessed under aerobic
conditions in a suspension containing 2 x 105 cells ml-'. Cell
survival was estimated by both colony formation and MTT
serial dilution assay. Hypoxic cell radiosensitivity was
estimated in cell suspensions and in cell micropellets.
The hypoxia in micropellets was achieved by metabolic
oxygen depletion using the following procedure. Cells
(5 x 105) in 200 ,ul of medium were transferred into 200 ,ul
plastic micropipetter tips closed at the end by flame.
Radiosensitisers at indicated concentrations were added
during the preparation of cell suspensions. The tips were
placed in sterile plastic tubes, which were used as holders.
The tubes contained 0.5 ml of water to ensure heat
conductivity. Afterwards cells were centrifuged at 300 g for
5 min, resulting in the formation of a micropellet at the end
of the tips. Generally, cell pellets were incubated for 10 min
at 37°C before irradiation to induce metabolic oxygen
depletion. After irradiation, the supernatant from cell pellets
was aspirated and the cells were resuspended in medium
(1 ml) using a 1 ml syringe with a 21 gauge needle. Cell
survival fractions were further determined by a MTT serial
dilution assay and the data were fitted to survival curves
according to the linear-quadratic model.
Hypoxia in a cell suspension (2.5-10 x 106 ml-1) was used
to compare the molar radiosensitising potency SNP, GSNO
and etanidazole, and to estimate the radioprotective activity
of the NO scavengers carboxy-PTIO and oxyhaemoglobin. In
these experiments, hypoxia was achieved by repeated vacuum
evacuation/injection (both 30 s) of 5% carbon dioxide/95%
nitrogen for 20 min. Hypoxic cells in suspension were
incubated for 10 min at 37°C, irradiated and processed as
described above.
MTT serial dilution assay
The MTT assay measures the number of metabolically active
cells by quantification of their ability to reduce MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to
water-insoluble formazan crystals. To assess cell survival
after irradiation we used a MTT assay adapted for
radiobiological experiments by Carmichael et al. (1987),
which we modified as follows. Cells were seeded into 96-
well plates at eight serial dilutions using a 0.5 log dilution
factor and a starting inoculum of 32 x 103 cells per well
(dilution= 1). This allowed the useful range of the assay to be
extended up to 3 logs of cell kill. Routinely, serial dilutions
from control and irradiated samples were produced directly
in the plates by sequential mixing 93 ,ul of cell suspension
with 200 ,ul of medium prefilled in plates. Cultures were
allowed to grow for five cell-doubling times. To prepare for
the MTT assay, the plates were emptied of medium by quick
decantation and drying on filter paper. The assay was
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performed for 3 h at 37C in 50,l of fresh medium
containing 0.5 mg ml-' MTT. The reaction was stopped by
addition of 200 ,l of dimethylsulphoxide (DMSO)-0.05 M
hydrochloric acid. The formazan crystals were left to dissolve
in the lower layer of DMSO for 5-10 min at 37°C.
Afterwards the DMSO and medium layers were mixed by
repeated pipetting and the absorbency was measured at
540 nm. The absorbency data were expressed as a percentage
relative to the maximal absorbency in the control sample, and
were plotted against the corresponding dilutions to produce
absorbency-dilution curves for each of the samples, as
demonstrated in Figure 1. Finally, the dilutions of the control
(C) and treated (T) samples were determined at the level of
10% absorbency and the survival fractions for all treated
samples were calculated at T/C. The same protocol was used
to estimate the direct cytotoxicity of SNP.
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Figure 1 Estimation of the radiosensitivity of aerobic PSNl/
ADR cells by an MTT serial dilution assay. (a) Primary data of a
representative experiment. Aerobic cells in a cell suspension were
subjected to irradiation at 0 (O), 2 (A), 4 (A ), 6 (A) and 8
(A)Gy, and serial dilutions of the samples were seeded into a 96-
well plate. After a 5 day incubation period, an MTT assay was
performed and the absorbency data were plotted against the
corresponding dilutions. The dilutions of the control (C) and
treated (T) samples were determined at the level of 10% of
absorbency (dashed line) as indicated by arrows for 0 and 6Gy,
and the survival fractions for all treated samples were calculated
at T/C. (b) The survival curve was fitted according to the linear-
quadratic model using survival data of three experiments.Hypoxic cell radiosensitisation by sodium nitroprusside
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Colony formation assay
Control and irradiated cells were analysed for colony
formation using a serial dilution approach analogous to
that described for the MTT serial dilution assay. Briefly,
serial dilutions of the cell suspensions were seeded into six-
well plates and incubated for seven cell-doubling times.
After staining with crystal violet, colonies containing at
least 50 cells were counted. The number of colonies was
plotted against the corresponding dilutions to produce
colony count-dilution curves for each of the samples.
Finally, the dilutions of the control (C) and treated (T)
samples were determined at the level of 20 colonies and the
survival fractions for all treated samples were calculated as
T/C.
Cellular radiosensitivity and radiosensitisation
The cellular radiosensitivity was expressed as SF2 (survival
fraction at 2 Gy) and MID (mean inactivation dose, in Gy)
after linear-quadratic fitting of the dose-survival data (Fertil
and Malaise, 1985). The radiation doses usually involved in
analysis were 2, 4, 6 and 8 Gy for oxic cells, 4, 8, 12 and
16 Gy for hypoxic cells, and 2, 4, 8 and 12 Gy for hypoxic
cells exposed to radiosensitisers. The enhancement ratios for
oxygen and chemical radiosensitisers were calculated at the
levels of 0.75, 0.32 and 0.1 survival fraction for oxic cells or
from the MID values. The enhancement ratios under hypoxic
conditions were obtained by dividing the radiation dose of
hypoxic cells by the radiation dose of oxic cells (or hypoxic
cells plus radiosensitiser). Similarly, the enhancement ratios
under aerobic conditions were obtained by dividing the
radiation dose for oxic cells by the radiation dose of oxic cells
plus radiosensitiser.
Bioactivation ofsodium nitroprusside
Bioactivation of SNP was monitored by the accumulated
cyanide using a methaemoglobin-based spectroscopic assay
(Smith and Kruszana, 1974). PSN1/ADR cells (10-
100 x 106 cells ml-') were incubated in the presence of
0.1 mM SNP and 0.1 mM methaemoglobin at 37°C with
constant shaking. At the indicated time points the reaction
was stopped by a 30-fold dilution with cold phosphate-
buffered saline (PBS). Afterwards, samples were centrifuged
for 2 min at 500 g and the cyanide -methaemoglobin
complex in the supernatant was quantified by an increase in
absorbency at 425 nM. A calibration curve was obtained with
dilutions of sodium cyanide in the range 0.01-0.1 mM.
The radioprotective effect of nitric oxide scavengers
PSN1/ADR cells (10 x 106 cells ml-') were incubated in the
presence of 0.1 mM SNP and 1 mM GSNO under conditions
of hypoxia induced by 5% carbon dioxide/95% nitrogen as
described above. When used, the scavengers carboxy-PTIO
and oxyhaemoglobin were added to produce final concentra-
tions of 1 and 0.1 mM respectively. After 10 min preincuba-
tion at 37°C cell suspensions were irradiated at 8 Gy and
analysed for cell survival by the MTT serial dilution assay.
Amperometric measurement of nitric oxide
All measurements were conducted at 37°C under a 5%
carbon dioxide/95% nitrogen atmosphere with periodic gentle
stirring. To assess bioreductive generation of NO, PSN1/
ADR cells (32 x 106 cells ml-') were incubated in 150 jil of
medium containing 0.32 mM SNP or GSNO. Spontaneous
NO release from SNP and GSNO was estimated using the
same procedure but in the absence of cells. The NO signal
was registered every minute by a Iso-NOP200 microsensor
connected to an ISO-NO Mark II meter (both from World
Precision Instruments, Hertfordshire, UK). The selectivity of
the microsensor is provided by the electrode-coating
membrane, which is permeable only to free NO. The
selectivity of the microsensor was confirmed by using the
NO-specific scavenger carboxy-PTIO. This agent was injected
in a volume of 5 ,ul to produce a final concentration of 1 mM.
The calibration of the microsensor was performed according
to the manufacturer's instructions.
DNA breakage
Hypoxic PSN1 cells in micropellets were irradiated at 8 Gy as
described above. Parallel samples were analysed for cell
survival by the MTT serial dilution assay and for DNA
breakage. The frequency of single-strand DNA breaks was
measured by an alkaline elution technique as described
previously (Delvaeye et al., 1993). Briefly, 5 x 105 cells were
lysed onto a 0.8-pm-pore polycarbonate filter (25 mm in
diameter) in a sarcosyl-sodium chloride-EDTA solution
(pH 10). The cell lysate was washed with 5 ml of 0.02 M
EDTA and DNA was eluted at the rate of 0.5 ml h-' in 8 ml
of tetrapropylammoniumhydroxid buffer at pH 12.2. The
DNA content in the fractions (8 x 2 h) as well as DNA
retained on the filter was quantified by a Hoechst dye 33258
fluorometric assay. The frequency of single-strand DNA
breaks was expressed as Gy equivalents.
Statistics
All assays were repeated three times. Data are expressed as
arithmetical means (symbols) with corresponding standard
deviations (bars).
Results
Intrinsic radiosensitivity of human pancreatic tumour cells
The intrinsic radiosensitivity of aerobic cells was assessed by
the MTT serial dilution assay. The primary data and their
analysis providing the survival curve are demonstrated in
Figure 1 for the cell line PSN1/ADR. Radiation-survival
curves for the other eight human pancreatic tumour cell lines
are shown in Figure 2. The range of intrinsic radiosensitivity
was considerable, and SF2 varied from 0.46 (PSN1) up to
0.75 (Panc-1). Of interest is the observation that selection of
PSN1/ADR cells for doxorubicin resistance resulted in
enhanced radiosensitivity compared with the parental PSN1
cells (Figures 1 and 2). This cell line was used further to
study the radiosensitising effects and pharmacology of SNP
but was not involved in correlation analysis because of its
artificial origin.
In this study we have used also an alternative approach to
characterise the initial parts of survival curves using the
model-free parameter MID introduced by Fertil and Malaise
(1985). The MID values in normoxia for PSN1, PT45, Mia
Paca 2, PaTu 2, HPAF, Panc-1, Colo 357 and A818-7 were
2.4, 2.9, 3.1, 3.6, 3.8, 4.0, 4.6 and 6.5 Gy respectively. Human
pancreatic tumour cells possess high intrinsic radioresistance
similar to that reported for melanomas and glioblastomas by
these authors (2.1-2.7 and 1.6-4.6 Gy respectively). The
correlation coefficient (R) of MID and SF2 was 0.76. MID
and SF2 values correlated with the doubling times (R = 0.98
and R=0.70 respectively).
We also re-evaluated the aerobic radiosensitivity using a
colony formation assay (Figure 2). We found MID values in
the range of 1.6-4.9 Gy, which correlated (R=0.88) with the
MID of the MTT assay, but with a reduction of 23% in the
mean value. The colony formation assay, however, presented
several problems when applied to some of the cell lines of the
panel. MiaPaca 2 and PT45 clearly detached and produced
daughter colonies. Incubation of Colo 357, Panc-1, HPAF
and PaTu 2 cells in micropellets provoked appearance of
aggregates and fused colonies. The MTT serial dilution assay
avoided these problems, therefore we have chosen to use it
for further studies of radiosensitivity in this panel of cell
lines.Comparison ofradiosensitisingpotency ofsodium nitroprusside,
S-nitroso-L-glutathione and etanidazole
The radiosensitising potency of SNP, GSNO and etanidazole,
used as a reference, was compared in PSN1 cells at 8 Gy.
Hypoxic cells in suspension rather than in a pellet were used to
control more accurately the extracellular concentration of the
agent. All three agents exerted a distinct radiosensitising effect
at non-cytotoxic concentrations, with SNP being approxi-
mately 10-fold more potentthan the others (Figure 3). Thehigh
radiosensitising potency ofSNP was the rationale for extended
radiobiological and pharmacological studies.
Hypoxic cell radioresponse and radiosensitising potency of
sodium nitroprusside in a panel ofhuman pancreatic tumour
cell lines
Hypoxic cell radiosensitivity and radiosensitising effects of
SNP in human pancreatic tumour cell lines are summarised
in Figure 4 and analysed in more detail for the cell lines
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Panc-I and PSN1/ADR in Table I. To access hypoxic cell
radiosensitivity, we used a model of metabolic hypoxia in a
micropellet of cells (0.5 x 106) in plastic pipette tips.
Preliminary experiments showed that hypoxic radioprotec-
tion could be obtained within 5 min of incubation at 37°C
and that cell viability was not affected during an additional
incubation up to 15 min. Although a limited diffusion of
oxygen through the plastic walls may be present, we found
no difference in hypoxic cell radioprotection between plastic
tips and conical glass tubes (data not shown). As shown
for normoxia in Table I, the oxygen enhancement ratios
(OERs) were increased at lower survival fractions. At a
survival fraction of 0.1 the OER was 2.7-2.9, close to that
observed by Mitchell et al. (1993) for a dense cell
suspension in sealed syringes, hence confirming the
presence of deep hypoxia in the pellet. The mean MID
value for a panel of human tumour pancreatic cells
was 9.6 (6.6-12.9) Gy in hypoxia compared with 3.9
(2.4-6.5) Gy for oxic cells, giving an overall OER of
2.5+0.29 (Figure 4).
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Figure 3 Comparison of the radiosensitising potency of sodium
nitroprusside, S-nitroso-L-glutathione and etanidazole in hypoxic
PSN1 cells in suspension (2.5 x 106ml-). The cell survival at
8Gy in the presence of non-cytotoxic concentrations of sodium
nitroprusside (O), S-nitroso-L-glutathione (A) and etanidazole
(Cl) was measured under hypoxic conditions induced by 95%
nitrogen-5% carbon dioxide. The cell survival at 8Gy without
radiosensitiser in normoxia and hypoxia is indicated by arrows.
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Figure 2 Radiation -survival curves of a panel of human
pancreatic tumour cell lines. The survival curves represent the
linear-quadratic fits obtained from the survival fractions of
aerobic cells using a colony formation assay (0) and the MTT
serial dilution assay (0), and of hypoxic cells using the MTT
serial dilution assay (A).
Figure 4 Hypoxic cell radiosensitivity and the radiosensitising
potency of sodium nitroprusside in a panel of human tumour
pancreatic cell lines. The mean inactivation doses of oxic cells
(A), hypoxic cells (A) and hypoxic cells exposed to sodium
nitroprusside at 0.1 mM (El) were plotted against cumulative
frequency in the order of increasing aerobic radioresistance.
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Table I Radiosensitising properties of sodium nitroprusside in Panc-I and PSN1/ADR cells
Enhancement ratio at survivalfractionsb
Cell line and conditions MID (Gy)a 0.75 0.32 0.1
Panc-l cells
Hypoxia 10.6+0.92
Normoxia 3.97+0.37 2.46 2.64 2.70
Hypoxia+SNP (mM)
0.01 8.41+1.15 1.34 1.23 1.19
0.032 6.79+0.48 1.88 1.52 1.39
0.1 5.34+0.39 2.85 2.02 1.67
0.32 4.65+0.29 3.54 2.39 1.88
1.0 5.03+±0.67 3.17 2.18 1.75
3.2 6.45±0.83 1.98 1.60 1.46
PSN1/ADR cells
Hypoxia 5.97 +0.58
Normoxia 2.18+0.19 2.43 2.74 2.92
Hypoxia+SNP (mM)
0.01 4.89+0.056 1.19 1.22 1.24
0.032 4.41 +0.36 1.19 1.36 1.46
0.1 3.04+0.18 1.88 1.98 2.04
0.32 2.24+0.063 2.94 2.75 2.62
1.0 2.58+0.32 2.90 2.48 2.18
3.2 4.03+0.74 1.67 1.53 1.44
Normoxia+0.1 mM SNP 2.28+0.38 0.89 0.95 0.97
aMID, mean inactivation dose, was measured under the specified conditions. bThe enhancement ratios werecalculated from thelinear-quadratic
fits at the survival fractions of0.75, 0.32, and 0.1 in normoxia. Sodium nitroprusside (SNP) was slightly cytotoxic at 1-3.2 mm, therefore the
survival curves and radiosensitisation effects have been corrected for direct cytotoxicity.
To study the radiosensitising effects of SNP, this
compound was added to the cell suspensions before
formation of pellets by centrifugation. The radiosensitising
activity of SNP remained stable when the incubation time of
the pellets at 37°C during the induction of hypoxia varied
between 5 and 20 min. A concentration-dependent radio-
sensitising effect was found in the range of 0.01-0.3 mM
(Table I). In contrast to oxygen, SNP showed a higher
radiosensitising effect at survival fractions of 0.32-0.75 than
at 0.1, corresponding to radiation doses of2-4 and 8- 12 Gy
respectively. Under aerobic conditions, SNP did not sensitise
cells to radiation.
The radiosensitising potency of SNP was further evaluated
in a panel ofeight cell lines (Figure 4). SNP at 0.1 mm was a
potent hypoxic cell radiosensitiser with a mean enhancement
ratio of 1.9 and an overall efficiency of 76% compared with
oxygen. In the most radioresistant cell lines (A818-7, Colo-357,
Panc-I and HPAF), we observed a reduced radiosensitising
effect that could be improved by increasing the SNP
concentration up to 0.3 mM (shown in Table I for Panc-1).
Bioactivation rate ofsodium nitroprusside
It is known that in the presence of cells or reducing agents
SNP {Na2[(CN)5FeNO]} undergoes reductive activation
resulting in the generation of NO, CN and cyanoferrate
(Bates et al., 1991). The production rate of NO is difficult to
measure in a dense cell suspension because of the fast
reaction of this radical with multiple cellular and extracellular
targets. Therefore, we preferred to measure the CN ion,
which is a stable metabolite and can be quantitatively
detected by a spectroscopic methaemoglobin assay. The
accumulation rate of SNP-derived CN was measured at
37°C in the range 10-100 x 106 cells ml-', corresponding to
3-30% (v/v) of the cell density in the pellet (Figure 5). At a
maximal cell density only one of five molecules of CN was
released from SNP even at prolonged incubation times of up
to 32 min. As the release of the first molecule of CN is
immediately followed by the generation of NO (Bates et al.,
1991), an equimolar production of CN and NO is expected.
At 3-30% cell density, the half-life of SNP linearly decreased
from 31 to 3.2 min, suggesting a value ofaround 1 min in the
case of a micropellet. This would imply complete decomposi-
tion of SNP in pellets at the time of irradiation. In the
absence ofcells no CN release was detected (data not shown).
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Figure 5 Dependence of the bioactivation rate of sodium
nitroprusside on cell density as measured by the release of CN.
The decomposition of sodium nitroprusside was monitored at a
concentration of0.1 mm at 37°C in the jresence of 10 (o), 32 (0)
and 100 (0)x 106PSNI/ADRcellsml- . The half-life of sodium
nitroprusside calculated at the level of 50pM CN (interrupted line)
was 31, 11 and 3.2 min respectively.
The effect of NO scavengers on the radiosensitising activity of
sodium nitroprusside and S-nitroso-L-glutathione
SNP may exert radiosensitisation through either NO or CN
as detailed in the 'Discussion'. We tested the radiosensitising
activity of sodium cyanide at a concentration corresponding
to complete decomposition of SNP, resulting in the release of
one molecule of CN. Sodium cyanide caused radiosensitisa-
tion, but could account only for 17% of the effect of SNP in
suspensions (Figure 6) and 40% in pellets (data not shown).
However, regarding the half-life of 31 min in suspensions
(Figure 5), the real concentration of SNP-derived CN at the
time of irradiation should not exceed 0.02 mM and CN alone
could cause only marginal radiosensitisation. Therefore, we
attempted to explore the role ofNO using oxyhaemoglobin, a
well-characterised scavenger of NO, and carboxy-PTIO, a
specific NO oxidiser (Akaike et al., 1993). The radio-
sensitising activity of GSNO (1 mM) in a suspension of
PSN1 cells (10 x 106 cells ml-') was substantially attenuated
by both scavengers, and oxyhaemoglobin was found to
abrogate completely the radiosensitising action (Figure 6). In
the case of SNP (0.1 mM), the radioprotective efficiency of
NO scavengers was lower but remained significant.
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Figure 6 Modulation of the radiosensitising effects of S-nitroso-
L-glutathione and sodium nitroprusside by the nitric oxide
scavengers carboxy-PTIO and oxyhaemoglobin in hypoxic PSN1
cells irradiated at 8Gy. The cell survival in the presence of 1.0mM
S-nitroso-L-glutathione (GSNO), 0.1 mm sodium nitroprusside
(SNP) or 0.1 mm sodium cyanide (CN) was measured under
hypoxic conditions induced by 95% nitrogen-5% carbon
dioxide. Carboxy-PTIO (PTIO) and oxyhaemoglobin (Hb) were
used at 1.0 and 0.1mm respectively. The cell survival at 8Gy
without radiosensitiser in normoxia and hypoxia is indicated by
arrows.
Amperometric measurement of NO generated by sodium
nitroprusside and S-nitroso-L-glutathione
As NO scavengers demonstrated diminished efficiency in
abrogating SNP-mediated radiosensitisation (see above), we
studied in more detail the mechanism of NO release using a
NO-specific microsensor. This sensor measures only free
radical NO that can be directly released from NO donors in
extracellular space or appears there because of diffusion from
the intracellular NO pool. SNP generated NO almost
exclusively by a bioreductive mechanism (Figure 7), and the
low background of spontaneous NO release was probably a
result of its known photosensitivity (Bates et al., 1991). The
addition of carboxy-PTIO resulted in complete scavenging of
the NO signal in contrast to an only partial radioprotective
effect (Figure 6). GSNO revealed a substantial background of
spontaneous NO release and, strikingly, the total signal of
extracellular NO exceeded that of SNP by 2.9-fold.
The effect ofsodium nitroprusside on radiation-induced DNA
breakage
NO is believed to radiosensitise hypoxic cells by a mechanism
of DNA damage fixation similar to oxygen (Mitchell et al.,
1993). However, no experimental support for this hypothesis
exists at present. Therefore, we examined the radiosensitising
effects of SNP in relation to DNA breakage in a wide
concentration range of 0.01-3 mM (Figure 8). These effects
have been corrected for the direct cytotoxicity ofSNP apparent
at 1-3 mm. Hypoxic PSN1 cells irradiated at 8 Gy showed a
reduced frequency of single-strand DNA breaks that may be
attributed to the mechanism of hypoxic cell radioprotection.
Hypoxic cell radiosensitisation by 0.01-0.3 mM SNP was
paralleled by anincreasing level ofDNAbreakage approaching
that observed in oxic cells. The upper concentrations of SNP
were cytotoxic and caused DNA damage but did not further
enhance radiosensitivity or DNA breakage. It is noteworthy
that the radiosensitising potency of SNP in pellets (Figure 8)
and in diluted cell suspensions (Figures 3 and 6) was similar.
Discussion
Our analysis of radiation responses in a panel of eight human
pancreatic tumour cell lines suggests that both intrinsic and
hypoxia-induced radioresistance may contribute to failure of
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Figure 7 Amperometric measurement of NO generated by
sodium nitroprusside and S-nitroso-L-glutathione. The release of
NO from sodium nitroprusside (a) and S-nitroso-L-glutathione (b)
was estimated by a Iso-NOP200 microsensor at 37°C, under a 5%
nitrogen-5% carbon dioxide atmosphere. The spontaneous and
bioreductive release of NO was measured respectively in the
absence (0) and presence (A) of PSN1/ADR cells
(32 x 106cellsml-1). The NO scavenger carboxy-PTIO (PTIO)
was added after 6min incubation (closed symbols) to produce a
final concentration of 1 mM.
local control in pancreatic cancer. To analyse cellular
radioresistance we preferred to use the model-free parameter
MID introduced by Fertil and Malaise (1985) rather than
SF2. The enhancement ratios of radiosensitisers cannot be
calculated directly from SF2 data. Furthermore, SF2 in
hypoxic cells is frequently higher than 0.8 and therefore
difficult to measure accurately. As determined by the MTT
serial dilution assay, all cell lines possessed a high level of
intrinsic radioresistance, in terms of MID values (2.4-
6.5 Gy), similar to those reported by Fertil and Malaise
(1985) for melanomas (2.1-2.7 Gy) and glioblastomas (1.6-
4.6 Gy). This conclusion was confirmed by a colony
formation assay, although the mean MID was 23% lower
(1.6-4.9 Gy). Possibly, the short-term MTT assay over-
estimates cell survival after irradiation because non-clono-
genic cells may remain metabolically active. To evaluate the
radiosensitising activity of bioreductive radiosensitisers, we
modified a model of metabolism-induced hypoxia previously
described by Mitchell et al. (1993). We used a cell micropellet
in plastic tips rather than a dense cell suspension as this
approach requires 10-30 times fewer cells and fewer
technical precautions to prevent reoxygenation. At a survivalHypoxic cell radiosensitisation by sodium nitroprusside
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Figure 8 Concentration-dependent effects of sodium nitroprus-
side on radiosensitivity (a) and DNA breakage (b) in hypoxic
PSN1 cells irradiated at 8Gy. The cell survival fraction (0, 0)
and the frequency of single-strand DNA breaks (A, A) were
measured for cells exposed to sodium nitroprusside alone (open
symbols) or with radiation (closed symbols). The dashed area
indicates the sensitising effect of sodium nitroprusside. The cell
survival and DNA breakage at 8Gy without radiosensitiser in
normoxia and hypoxia are indicated by arrows.
fraction of 0.1, OER was 2.7-2.9, indicating radiobiologi-
cally relevant hypoxia, as also observed in the model of
Mitchell et al. (1993).
SNP, a well-known bioreductive NO donor (Bates et al.,
1991), has been found to be an efficient radiosensitiser of
hypoxic cells at non-cytotoxic concentrations between 0.01
and 0.3 mM. In a panel of eight lines, SNP at 0.1 mM showed
a mean enhancement ratio of 1.9 compared with 2.5 for
oxygen. The molar radiosensitising potency of SNP was at
least 10-fold higher than that of etanidazole, a representative
of 2-nitroimidazoles undergoing clinical trials. Interestingly,
at survival fractions above 0.3, which are attributed to
clinically relevant doses of radiation (2-4 Gy), SNP
demonstrated an increased radiosensitising effect, whereas
oxygen showed a reduced effect. This phenomenon resembles
the recent findings on etanidazole and buthionine sulphox-
imine, whose radiosensitising effects, in contrast to oxygen,
were increased at high survival fractions (Skov and MacPhail,
1992, 1994). Under aerobic conditions SNP was not active,
presumably because of the rapid oxidation of NO. This
suggests that SNP is a specific radiosensitiser of hypoxic cells,
and that the same target could be implicated in the
mechanisms of SNP and oxygen-mediated radiosensitisa-
tion. This point of view is supported by our data on
radiation-induced DNA breakage under hypoxic conditions.
SNP in the range of 0.01-0.3 mM caused a concentration-
dependent enhancement of DNA breakage up to the level
observed in the presence of oxygen.
The mechanism of SNP-mediated radiosensitisation
appears to be complex as this agent generates two
radiobiologically active products - NO and CN. Douple
and Green (1980) described radiosensitisation of hypoxic
and oxic cells by SNP after a prolonged exposure time of
2 h, and speculated that SNP-derived CN may inhibit
cellular respiration and thereby 'spare' oxygen, a natural
radiosensitiser. However, no evidence of the radiosensitising
activity of CN itself was provided, and the accumulation
rate of CN in monolayer cultures was not estimated by the
authors. Our short-term experiments in cell suspensions with
controlled rates of SNP decomposition suggest that even
complete liberation of CN from SNP could account for less
than 17% of the radiosensitising effect. Instead, the role of
NO is supported by the reversing effect of the NO
scavengers carboxy-PTIO and oxyhaemoglobin on the
radiosensitising action of SNP and GSNO. Moreover, NO
in gaseous form or released from DEA/NO has previously
been shown to radiosensitise hypoxic cells (Mitchell et al.,
1993). Therefore, we conclude that SNP-derived NO by itself
can cause hypoxic cell radiosensitisation. On the other hand,
CN may contribute to the radiosensitising effect of SNP in
the in situ models of metabolic hypoxia as extensively
discussed by Douple and Green (1981). As the role of CN in
SNP-induced radiosensitisation appears to be limited, we
focused further analysis on the NO-mediated mechanism.
We considered NO as the common mediator responsible for
the radiosensitising effects of GSNO and SNP. GSNO was
involved in our study as a pure NO releaser, and has been
implicated in the intracellular pathways of NO redox forms
(Ignarro et al., 1981; Stamler et al., 1992; Clancy et al.,
1994).
The bioreductive generation ofNO from SNP is thought to
proceed via a one-electron transfer reduction at the cellular
membrane, which operates as a catalyser (Bates et al., 1991;
Rochelle et al., 1994). Thus, the half-life of SNP should be
correlated inversely with cell density, consistent with our
observations. In the case ofpellets, the calculated half-life was
around 1 min, indicating complete decomposition of SNP at
the time of irradiation. However, we found approximately the
same radiosensitising activity in pellets as in diluted cell
suspensions, wherein the rate ofSNP bioactivation declinedby
a factor of 30-100. Therefore, the rate of NO generation is
not predictive for the radiosensitising activity of SNP. We
hypothesise that in hypoxic cells an effective accumulation of
SNP-derived NO may occur at any cell density by transfer of
the NO radical to cellular targets, without its liberation into
the medium. This is in keeping with the reduced potency ofthe
NO scavengers carboxy-PTIO and oxyhaemoglobin to
counteract the radiosensitising effect of SNP compared with
that of GSNO. The model of a direct transfer of the SNP-
derived nitrosonium cation on membrane-bound thiols has
already been suggested (Rochelle et al., 1994). Direct
measurements of the extracellular NO concentration, using a
specific microsensor, are consistent with the above model.
Firstly, we detected only marginal spontaneous liberation of
NO from SNP in the absence of cells. Secondly, bioreductive
activation of SNP did not result in the generation of free NO
in the extracellular space at a rate that could explain the 10-
fold higher radiosensitising potency of SNP compared with
that of GSNO. Finally, the radiosensitising effect of SNP was
only partially abrogated by carboxy-PTIO, although the
extracellular NO signal completely disappeared. We stress
again that in cell suspensions the radiosensitising effect of CN
was negligible and could not explain the discrepancy between
the radioprotective and scavenging properties of carboxy-
PTIO. Therefore, intracellular NO adducts, but not the
extracellular pool of free NO, may confer SNP-mediated
radiosensitisation.
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In contrast to SNP, GSNO spontaneously liberated NO
into the medium and generated higher extracellular concen-
trations of NO by bioreduction. This increased pool of
extracellular NO was contradictory to the lower radio-
sensitising activity, which again confirms the lack of
correlation between NO production and radiosensitising
activity for bioreductive NO donors. Endogenously formed
GSNO is conceivably the major adduct of natural thiols, with
nitrosonium cation accumulated in cells after exposure to NO
(Ignarro et al., 1981; Stamler et al., 1992; Clancy et al., 1994).
As such, it may also be involved in the trapping and storing
of SNP-derived NO adducts in hypoxic cells, thereby
supporting delayed radiosensitisation. On the other hand,
increased levels of intracellular glutathione may slow down
the transfer of the SNP-derived NO towards DNA as a result
of trapping of the nitrosonium cation, and sustain intrinsic
radioresistance at the same time (Skov and MacPhail, 1992).
This could be one of the mechanisms underlying a decreased
radiosensitising effect of SNP in the more radioresistant cell
lines A818-7, Colo-357, Panc-I and HPAF. Hence, the
radiosensitising potency of SNP can be reduced in slow-
growing and well-differentiated tumour cells possessing
elevated radioresistance.
Recently, the NONOate complex DEA/NO has been
proposed as a hypoxic tumour cell radiosensitiser with a
dual action on both tumour and vascular cells (Mitchell et
al., 1993). The authors speculated that, besides direct
sensitisation of hypoxic tumour cells, DEA/NO may
improve tumour oxygenation and radiosensitisation because
of the vasodilatory effect on tumour vasculature. However,
the reduction in tumour blood flow and oxygenation due to
preferential peripheral vasodilatation and decrease in blood
pressure is also possible. Indeed, these alternative effects have
been already described for the vasodilators flunarizine and
hydralazine (discussed in Teicher et al., 1993). Another
limitation to the use of NO prodrugs may arise from their
side-effects on the nervous systems, which is responsive to
low concentrations of NO (Knowles and Moncada, 1994).
Therefore, the concentrations of NO required for radio-
sensitisation may be difficult to obtain in vivo for any NO
donor. The minimum concentration of SNP expected to exert
radiosensitisation is close to 0.01 mM. Such a concentration
in plasma is achievable at subtoxic doses in mice (Smith and
Kruszyna, 1974), but in humans a safety infusion protocol of
SNP used to maintain vasodilatation (<3 ,ug min-' kg-')
would not result in a sufficient level of NO equivalents. The
same problem applies to DEA/NO, which spontaneously
liberates NO with a constant half-life of 2.1 min (Maragos et
al., 1993). In metabolically induced hypoxia, DEA/NO
showed half-reversal of radioprotection at 0.3-0.5 mM,
whereas SNP reveals the same effect at a concentration of
0.1 mM and at similar or longer half-lives. The comparison of
the SNP and DEA/NO potency indicates that bioreductive
NO donors may evoke radiosensitising action at reduced
pharmacokinetic doses, a feature claimed also for other
bioreductive modifiers that exploit redox conditions in
hypoxic cells (Adams, 1992). At present, it is not clear
whether redox microenvironments in tumours might favour
the accumulation ofNO intermediates up to radiobiologically
active levels at tolerated doses of SNP. However, the
radiosensitising effect of infused SNP combined with
carbogen breathing has been clearly observed in Lewis
carcinoma-bearing mice (Teicher et al., 1993), thus warrant-
ing further in vivo studies of this promising bioreductive
radiosensitiser.
In conclusion, our studies in human pancreatic tumour cell
lines have provided a radiobiological rationale for the poor
radioresponsiveness in pancreatic cancer based on high
intrinsic cellular radioresistance. Additionally, we demon-
strated that SNP, a bioreductive NO donor, elicits efficient
hypoxic cell radiosensitisation through the generation of NO
and fixation of DNA damage. SNP, an active vasodilatory
drug with a long history in the treatment of hypertension,
may also be of value as a tumour radioresponse modifier.
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